fundvisualizer.com

Federated Hermes International Growth R6REIGX

Performance (before sales charge)

As of 10/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2022
Stock
6.86%
Non-U.S. Stock
88.85%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
4.29%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2022

Basic materials

4.85%

Consumer cyclical

11.25%

Financial services

8.21%

Real estate

1.66%

Consumer defensive

8.42%

Health care

17.77%

Utilities

2.15%

Communication services

3.09%

Energy

8.62%

Industrials

10.65%

Technology

19.05%

Top 10 holdings

As of 09/30/2022

Federated Hermes Inst Prime Val Obl IS
4.29%
AstraZeneca PLC ADR
3.93%
DBS Group Holdings Ltd
3.13%
Nestle SA
2.20%
Taiwan Semiconductor Manufacturing Co Ltd ADR
2.18%
Compass Group PLC
1.97%
Samsung SDI Co Ltd
1.96%
Tencent Holdings Ltd
1.96%
Reliance Industries Ltd
1.91%
Olympus Corp
1.83%
Fund assets

$657.4 Million

Share class

Inst

Morningstar category

Foreign Large Growth

Expense ratio

0.84%

Investment objective

Growth

Documents